Navigation Links
Tourette Patients Benefit From Behavioral Therapy: Study
Date:8/6/2012

By Alan Mozes
HealthDay Reporter

MONDAY, Aug. 6 (HealthDay News) -- Tourette Syndrome patients fare better when offered tic management therapy as opposed to support sessions solely focused on providing information about the neurological disorder, new research suggests.

The finding is based on a study of 122 patients between the ages of 16 and 55, all of whom struggle with the sudden and unwanted repetitive physical and verbal tics that characterize Tourette Syndrome.

"Typically, medication has been used to treat tics," explained study author Sabine Wilhelm, director of the OCD (obsessive-compulsive disorder) and Related Disorders Program at Massachusetts General Hospital/Harvard Medical School in Boston. "But many patients refuse or discontinue medications due to unwanted side effects."

"Behavior therapy," Wilhelm said, "takes a different approach from medication. Patients often report a premonitory urge -- that's an unpleasant sensation -- prior to engaging in the tic, and they engage in tics in order to relieve the urge. Behavior therapy helps patients to disrupt this pattern. In behavior therapy, patients learn to detect signs that a tic will likely occur and they are taught to engage in competing responses, which are behaviors that are physically incompatible with the impending tic. Thus, patients learn new ways to manage their tics."

"We tested a newer behavioral treatment for tics called Comprehensive Behavioral Intervention for Tics (CBIT)," she said. It "teaches patients to consider the impact of their environment on tics and incorporates procedures to reduce environmental influences that increase tics. The result of our study is exciting news for patients with tic disorders as they now have solid support for behavior therapy for tics."

Wilhelm and her colleagues from several other institutions (including Yale University and the University of Texas Health Science Center at San Antonio) report their findings in the August issue of the Archives of General Psychiatry. The research was supported by the U.S. National Institute of Mental Health.

Tourette syndrome is typified by a wide range of physical and verbal symptoms, which can include uncontrolled eye blinking, head-jerking, reaching out, touching, throat clearing, coughing, and at times the utterance or display of words, phrases, or movements that may involve cursing or the demonstration of socially inappropriate gestures.

However, Wilhelm stressed that to a large degree the public's popular notion of what constitutes Tourette syndrome is off-base, given that four-letter word declarations occur in only about 10 to 15 percent of Tourette patients.

That said, while Tourette syndrome often starts in early childhood and peaks by adolescence, the disorder continues to impair the quality of life of an estimated one in every 2,000 adults, for whom medication may prove problematic.

Between 2005 and 2009, Wilhelm's team focused on Tourette syndrome -- as well as chronic tic disorder -- in patients being treated at one of three outpatient research clinics.

For a 10-week period, roughly half the patients were offered eight sessions of standard patient support and education, which provided information concerning both the neurological underpinnings of the disorder and the range of effects and possible treatments.

The other half was given eight sessions of the comprehensive behavioral intervention, which focused on tic awareness to help patients detect early warning signs of an imminent tic; relaxation training; and so-called "competing-response training." This training teaches patients how to voluntarily engage in behaviors that might impede the onset of tics -- such as breathing rhythmically to block word bursts, or pressing the elbow into the torso to prevent arm thrusts. They also talked about management of situations that might raise the risk for experiencing a tic.

Patients in either group who were already on medications before the study launch continued to take them throughout.

Mental health evaluations revealed that more than 38 percent of those in the intervention group showed "significant" improvement, a figure that dropped to just about 7 percent among the support/education group.

Specifically, tic severity dropped by 26 percent among the behavioral intervention patients, but only by about 12 percent among the other group.

Follow-up testing further showed that behavioral-intervention patients who did derive benefit maintained their symptom improvement six months down the road.

"The obvious next step," Wilhelm said, "is to teach clinicians how to administer CBIT."

More information

For more on Tourette syndrome and therapy, visit the National Tourette Syndrome Association.

SOURCES: Sabine Wilhelm, Ph.D., director, OCD and Related Disorders Program, Massachusetts General Hospital/Harvard Medical School, Boston; August 2012 Archives of General Psychiatry


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Moffitt Cancer Center researcher & colleagues test new drug for patients with neuroendocrine tumors
2. Off-label drug use common, but patients may not know theyre taking them, Mayo finds
3. Trauma Patients at Higher Risk of Dying of Hypothermia: Study
4. Virtual Patients New Addition to Psychiatry?
5. New study suggests clinicians overlook alcohol problems if patients are not intoxicated
6. Genes May Be Key for Patients With Multiple Colon Polyps
7. Imaging Tests Up Among Advanced Cancer Patients
8. New Guidelines Say No to Screening EKGs for Low-Risk Patients
9. Diagnostic imaging increases among stage IV cancer patients on Medicare
10. Most Prostate Cancer Patients Dont Die From the Disease: Study
11. Breakthrough treatment reduces post-surgical scarring for glaucoma patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tourette Patients Benefit From Behavioral Therapy: Study
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , ... Allentown, Penn. , and OptiMed Specialty Pharmacy of ... business partnership to offer a strategic hub service that ... Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, and ... A spirometer is a medical device used to ...
(Date:9/12/2017)... Sept. 12, 2017   EcoVadis , the leading platform for environmental, ... first annual edition of its Global CSR Risk and Performance Index. The ... EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data points across ... ... ...
Breaking Medicine Technology: